On March 19, 2026, SelectQuote, Inc. (NYSE: SLQT) received a notice from the New York Stock Exchange (NYSE) indicating that the company is no longer in compliance with Section 802.01C of the NYSE Listed Company Manual. This non-compliance is due to the average closing price of the company's common stock being less than $1.00 per share over a consecutive 30 trading-day period. In response, SelectQuote has notified the NYSE of its intent to cure this deficiency and return to compliance with the continued listing standard. The company has a six-month cure period during which it can regain compliance if its stock price meets the required thresholds. SelectQuote's common stock will continue to be listed and traded on the NYSE during this period, provided it complies with other NYSE continued listing standards. The company recently reported strong fiscal second quarter 2026 results and executed a new $415 million credit facility, extending the majority of its debt maturities to 2031. Despite these positive developments, the stock price deficiency poses a significant challenge to the company's market standing and investor confidence.



Press Release distribution
National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.